| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pre-Eclampsia | 20 | 2020 | 202 | 4.400 |
Why?
|
| Pregnancy Complications | 14 | 2020 | 286 | 2.090 |
Why?
|
| Pregnancy | 66 | 2020 | 2334 | 1.800 |
Why?
|
| Gestational Age | 23 | 2020 | 389 | 1.120 |
Why?
|
| Infant Mortality | 15 | 2018 | 59 | 1.090 |
Why?
|
| Breast Feeding | 5 | 2020 | 159 | 1.030 |
Why?
|
| Infant, Newborn | 61 | 2020 | 2455 | 0.970 |
Why?
|
| Female | 117 | 2020 | 38074 | 0.870 |
Why?
|
| Infant, Low Birth Weight | 12 | 2005 | 84 | 0.850 |
Why?
|
| Body Mass Index | 5 | 2020 | 867 | 0.750 |
Why?
|
| Placenta | 2 | 2020 | 101 | 0.730 |
Why?
|
| Humans | 133 | 2020 | 68618 | 0.700 |
Why?
|
| Dietary Supplements | 4 | 2020 | 332 | 0.680 |
Why?
|
| Maternal Age | 10 | 2019 | 70 | 0.650 |
Why?
|
| Parity | 14 | 2017 | 71 | 0.640 |
Why?
|
| Pregnancy Outcome | 10 | 2012 | 157 | 0.610 |
Why?
|
| Cohort Studies | 18 | 2020 | 2358 | 0.610 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 73 | 0.610 |
Why?
|
| Pregnancy in Adolescence | 4 | 2012 | 33 | 0.590 |
Why?
|
| Endothelium | 1 | 2017 | 98 | 0.590 |
Why?
|
| Lactation | 3 | 2020 | 110 | 0.590 |
Why?
|
| Cholecalciferol | 3 | 2020 | 143 | 0.590 |
Why?
|
| Cesarean Section | 8 | 2008 | 101 | 0.590 |
Why?
|
| Hypertension | 6 | 2019 | 1535 | 0.560 |
Why?
|
| Mothers | 4 | 2012 | 172 | 0.520 |
Why?
|
| Vitamin D Deficiency | 3 | 2015 | 292 | 0.520 |
Why?
|
| Vitamins | 2 | 2015 | 134 | 0.500 |
Why?
|
| South Carolina | 28 | 2015 | 2752 | 0.490 |
Why?
|
| Bottle-Nosed Dolphin | 6 | 2013 | 86 | 0.490 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2013 | 931 | 0.480 |
Why?
|
| Perinatal Care | 3 | 2003 | 17 | 0.480 |
Why?
|
| Obesity | 4 | 2019 | 1076 | 0.470 |
Why?
|
| Adolescent | 33 | 2019 | 8912 | 0.470 |
Why?
|
| Adult | 47 | 2020 | 21403 | 0.470 |
Why?
|
| Pediatrics | 7 | 2015 | 341 | 0.460 |
Why?
|
| Infant | 24 | 2020 | 2891 | 0.450 |
Why?
|
| Infant, Premature | 14 | 2015 | 284 | 0.440 |
Why?
|
| Fetal Death | 4 | 2005 | 49 | 0.440 |
Why?
|
| Infant, Very Low Birth Weight | 5 | 2014 | 69 | 0.420 |
Why?
|
| Eclampsia | 3 | 2003 | 16 | 0.390 |
Why?
|
| Prenatal Care | 10 | 2013 | 117 | 0.380 |
Why?
|
| Reunion | 7 | 2020 | 7 | 0.360 |
Why?
|
| Bottle Feeding | 2 | 2020 | 20 | 0.350 |
Why?
|
| Gravidity | 3 | 2010 | 11 | 0.350 |
Why?
|
| Risk Factors | 27 | 2019 | 5731 | 0.350 |
Why?
|
| Paternity | 4 | 1999 | 4 | 0.340 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2009 | 20 | 0.340 |
Why?
|
| Bone Density | 2 | 2009 | 159 | 0.330 |
Why?
|
| Laparoscopy | 2 | 2008 | 237 | 0.330 |
Why?
|
| Water Pollutants, Chemical | 5 | 2013 | 328 | 0.330 |
Why?
|
| History, 20th Century | 4 | 2018 | 248 | 0.330 |
Why?
|
| Infant Care | 2 | 2002 | 31 | 0.330 |
Why?
|
| Hip Joint | 1 | 2009 | 64 | 0.320 |
Why?
|
| Intensive Care, Neonatal | 3 | 2005 | 38 | 0.320 |
Why?
|
| Medication Errors | 3 | 2015 | 116 | 0.310 |
Why?
|
| Pelvic Pain | 1 | 2008 | 11 | 0.310 |
Why?
|
| Maternal-Fetal Exchange | 4 | 2012 | 57 | 0.310 |
Why?
|
| Tissue Adhesions | 1 | 2008 | 21 | 0.310 |
Why?
|
| Hysterectomy | 1 | 2008 | 64 | 0.310 |
Why?
|
| Dystocia | 1 | 2008 | 4 | 0.310 |
Why?
|
| Incidence | 16 | 2019 | 1603 | 0.310 |
Why?
|
| Pregnancy Complications, Cardiovascular | 4 | 1996 | 34 | 0.310 |
Why?
|
| Milk, Human | 3 | 2020 | 147 | 0.300 |
Why?
|
| Marital Status | 5 | 2006 | 65 | 0.300 |
Why?
|
| Retrospective Studies | 29 | 2020 | 7277 | 0.300 |
Why?
|
| Birth Weight | 9 | 2007 | 186 | 0.300 |
Why?
|
| School Health Services | 2 | 2012 | 72 | 0.300 |
Why?
|
| Endometriosis | 1 | 2007 | 56 | 0.290 |
Why?
|
| Embryo Implantation | 3 | 2017 | 17 | 0.290 |
Why?
|
| Socioeconomic Factors | 12 | 2014 | 955 | 0.290 |
Why?
|
| Labor, Induced | 3 | 2008 | 18 | 0.290 |
Why?
|
| Vascular Diseases | 1 | 2007 | 94 | 0.290 |
Why?
|
| Male | 55 | 2016 | 37321 | 0.270 |
Why?
|
| Young Adult | 11 | 2020 | 5717 | 0.260 |
Why?
|
| Child | 20 | 2017 | 6405 | 0.260 |
Why?
|
| Personality | 1 | 2006 | 66 | 0.260 |
Why?
|
| Vitamin D | 5 | 2020 | 516 | 0.250 |
Why?
|
| Attitude | 1 | 2006 | 121 | 0.250 |
Why?
|
| Desensitization, Immunologic | 2 | 2015 | 25 | 0.250 |
Why?
|
| Infant, Newborn, Diseases | 4 | 2012 | 91 | 0.250 |
Why?
|
| Respiration, Artificial | 6 | 2014 | 190 | 0.250 |
Why?
|
| Delivery, Obstetric | 6 | 2017 | 58 | 0.240 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2004 | 11 | 0.240 |
Why?
|
| Ventilator Weaning | 5 | 2004 | 27 | 0.240 |
Why?
|
| Anesthesia, Conduction | 1 | 2004 | 14 | 0.240 |
Why?
|
| Weight Gain | 2 | 2005 | 135 | 0.240 |
Why?
|
| Infant Nutritional Physiological Phenomena | 2 | 2020 | 72 | 0.240 |
Why?
|
| Emergency Medical Services | 2 | 2008 | 225 | 0.230 |
Why?
|
| Hospitals, Maternity | 1 | 2003 | 1 | 0.230 |
Why?
|
| Organizational Affiliation | 1 | 2003 | 8 | 0.230 |
Why?
|
| Family Planning Services | 2 | 2003 | 18 | 0.230 |
Why?
|
| Hyaline Membrane Disease | 4 | 2004 | 10 | 0.230 |
Why?
|
| Retinopathy of Prematurity | 2 | 2001 | 34 | 0.230 |
Why?
|
| Treatment Outcome | 11 | 2015 | 7029 | 0.230 |
Why?
|
| Pulmonary Surfactants | 3 | 2014 | 41 | 0.220 |
Why?
|
| Regional Medical Programs | 3 | 1993 | 22 | 0.220 |
Why?
|
| Fertility | 2 | 2003 | 60 | 0.210 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2002 | 10 | 0.210 |
Why?
|
| Needs Assessment | 1 | 2003 | 186 | 0.210 |
Why?
|
| Comorbidity | 2 | 2017 | 1426 | 0.210 |
Why?
|
| Models, Statistical | 2 | 2004 | 448 | 0.200 |
Why?
|
| Postoperative Complications | 3 | 2012 | 1615 | 0.200 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2002 | 16 | 0.200 |
Why?
|
| Estrus | 1 | 2002 | 14 | 0.200 |
Why?
|
| Adaptation, Biological | 1 | 2002 | 14 | 0.200 |
Why?
|
| Hair | 1 | 2002 | 46 | 0.200 |
Why?
|
| Drug Prescriptions | 2 | 2015 | 135 | 0.190 |
Why?
|
| Fluorocarbons | 2 | 2013 | 82 | 0.190 |
Why?
|
| Preventive Health Services | 1 | 2002 | 86 | 0.190 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2001 | 8 | 0.190 |
Why?
|
| Ultrasonography, Prenatal | 4 | 2015 | 79 | 0.190 |
Why?
|
| Hospital Mortality | 3 | 2015 | 384 | 0.190 |
Why?
|
| Age of Onset | 2 | 2019 | 188 | 0.190 |
Why?
|
| Child, Preschool | 14 | 2016 | 3187 | 0.190 |
Why?
|
| Analgesics, Opioid | 2 | 2017 | 498 | 0.190 |
Why?
|
| Pain | 1 | 2004 | 472 | 0.190 |
Why?
|
| Perinatology | 2 | 1991 | 8 | 0.190 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 3 | 2008 | 46 | 0.190 |
Why?
|
| Hepatitis B Vaccines | 1 | 2020 | 11 | 0.190 |
Why?
|
| Maternal Welfare | 2 | 2007 | 17 | 0.180 |
Why?
|
| Late Onset Disorders | 1 | 2020 | 4 | 0.180 |
Why?
|
| Hepatitis B | 1 | 2020 | 42 | 0.180 |
Why?
|
| Environmental Monitoring | 3 | 2011 | 180 | 0.170 |
Why?
|
| Databases, Factual | 3 | 2020 | 622 | 0.170 |
Why?
|
| Blood Transfusion | 2 | 2001 | 205 | 0.170 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 67 | 0.170 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2015 | 450 | 0.170 |
Why?
|
| History, 21st Century | 2 | 2017 | 127 | 0.170 |
Why?
|
| Infant Death | 1 | 2018 | 1 | 0.170 |
Why?
|
| Logistic Models | 9 | 2010 | 1420 | 0.170 |
Why?
|
| Child Behavior Disorders | 2 | 2008 | 69 | 0.160 |
Why?
|
| Risk Adjustment | 1 | 1998 | 49 | 0.160 |
Why?
|
| Double-Blind Method | 5 | 2015 | 1738 | 0.160 |
Why?
|
| Delivery of Health Care | 1 | 2002 | 445 | 0.150 |
Why?
|
| Hospitals, Community | 2 | 1998 | 64 | 0.150 |
Why?
|
| Global Health | 1 | 2018 | 136 | 0.150 |
Why?
|
| Multivariate Analysis | 3 | 2014 | 1046 | 0.150 |
Why?
|
| History, 19th Century | 1 | 2017 | 95 | 0.150 |
Why?
|
| Arsenic | 2 | 2007 | 46 | 0.150 |
Why?
|
| Selenium | 2 | 2007 | 36 | 0.150 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2014 | 34 | 0.150 |
Why?
|
| Adipose Tissue | 2 | 2010 | 221 | 0.150 |
Why?
|
| Hydrocephalus | 2 | 2016 | 40 | 0.150 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 2014 | 113 | 0.150 |
Why?
|
| Breech Presentation | 1 | 2017 | 11 | 0.150 |
Why?
|
| Medicaid | 3 | 2015 | 302 | 0.140 |
Why?
|
| Metals | 2 | 2007 | 100 | 0.140 |
Why?
|
| Acetaminophen | 1 | 2017 | 111 | 0.140 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2016 | 16 | 0.140 |
Why?
|
| Cocaine | 1 | 2002 | 555 | 0.140 |
Why?
|
| Patient Safety | 2 | 2015 | 202 | 0.140 |
Why?
|
| Reproduction | 2 | 2009 | 48 | 0.140 |
Why?
|
| Prospective Studies | 11 | 2012 | 3705 | 0.140 |
Why?
|
| Biomarkers | 1 | 2002 | 1593 | 0.130 |
Why?
|
| Head | 1 | 2016 | 59 | 0.130 |
Why?
|
| Risk Assessment | 3 | 2018 | 2007 | 0.130 |
Why?
|
| Maternal Health | 1 | 2015 | 8 | 0.130 |
Why?
|
| Regression Analysis | 8 | 2008 | 737 | 0.130 |
Why?
|
| Neonatal Nursing | 1 | 2015 | 16 | 0.130 |
Why?
|
| Middle Aged | 10 | 2017 | 21147 | 0.130 |
Why?
|
| Reproducibility of Results | 4 | 2015 | 2077 | 0.130 |
Why?
|
| Time Factors | 9 | 2015 | 4655 | 0.130 |
Why?
|
| Rhinitis, Allergic | 1 | 2015 | 22 | 0.130 |
Why?
|
| Age Factors | 8 | 2010 | 1864 | 0.130 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2015 | 38 | 0.130 |
Why?
|
| Indomethacin | 1 | 2015 | 107 | 0.120 |
Why?
|
| Pilot Projects | 7 | 2020 | 1342 | 0.120 |
Why?
|
| Hospital Costs | 1 | 2015 | 117 | 0.120 |
Why?
|
| Uterus | 1 | 2015 | 77 | 0.120 |
Why?
|
| Epidemiologic Methods | 2 | 2009 | 83 | 0.120 |
Why?
|
| Models, Biological | 1 | 1999 | 981 | 0.120 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2014 | 22 | 0.120 |
Why?
|
| Aspirin | 1 | 1996 | 295 | 0.120 |
Why?
|
| Fetal Growth Retardation | 1 | 2015 | 56 | 0.120 |
Why?
|
| Intensive Care Units, Pediatric | 3 | 2012 | 101 | 0.120 |
Why?
|
| Fetus | 1 | 2015 | 157 | 0.120 |
Why?
|
| Asthma | 2 | 2013 | 345 | 0.120 |
Why?
|
| Drug Overdose | 1 | 2015 | 67 | 0.120 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2014 | 43 | 0.120 |
Why?
|
| Time-to-Treatment | 1 | 2015 | 117 | 0.120 |
Why?
|
| Hypoxia-Ischemia, Brain | 2 | 2005 | 56 | 0.120 |
Why?
|
| Odds Ratio | 5 | 2004 | 880 | 0.120 |
Why?
|
| Hypothermia, Induced | 2 | 2005 | 93 | 0.120 |
Why?
|
| HLA Antigens | 1 | 2014 | 82 | 0.120 |
Why?
|
| Premature Birth | 1 | 2015 | 150 | 0.110 |
Why?
|
| Exercise Test | 1 | 2014 | 242 | 0.110 |
Why?
|
| Point-of-Care Systems | 1 | 2014 | 115 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 240 | 0.110 |
Why?
|
| Ergocalciferols | 1 | 2013 | 40 | 0.110 |
Why?
|
| Prognosis | 7 | 2018 | 2093 | 0.110 |
Why?
|
| Health Surveys | 1 | 2014 | 489 | 0.110 |
Why?
|
| Fetal Blood | 2 | 2012 | 131 | 0.110 |
Why?
|
| Positive-Pressure Respiration | 2 | 2008 | 27 | 0.110 |
Why?
|
| Tissue Donors | 1 | 2014 | 195 | 0.100 |
Why?
|
| Environment | 1 | 2013 | 115 | 0.100 |
Why?
|
| Alprostadil | 1 | 2012 | 20 | 0.100 |
Why?
|
| Tissue and Organ Procurement | 1 | 2014 | 164 | 0.100 |
Why?
|
| Cardiac Output, Low | 1 | 2012 | 52 | 0.100 |
Why?
|
| Child Health Services | 1 | 2012 | 50 | 0.100 |
Why?
|
| Parents | 1 | 2014 | 312 | 0.100 |
Why?
|
| Child Abuse, Sexual | 1 | 1993 | 150 | 0.100 |
Why?
|
| Transposition of Great Vessels | 1 | 2012 | 51 | 0.100 |
Why?
|
| Cystic Fibrosis | 2 | 2005 | 283 | 0.100 |
Why?
|
| Transportation of Patients | 1 | 1991 | 46 | 0.100 |
Why?
|
| Graft Survival | 1 | 2014 | 465 | 0.100 |
Why?
|
| Obstetric Labor Complications | 2 | 2012 | 20 | 0.100 |
Why?
|
| United States | 10 | 2015 | 7367 | 0.100 |
Why?
|
| Insurance Coverage | 1 | 2012 | 99 | 0.100 |
Why?
|
| Caregivers | 1 | 2014 | 365 | 0.090 |
Why?
|
| Heart Transplantation | 1 | 2014 | 328 | 0.090 |
Why?
|
| Health Promotion | 1 | 1995 | 407 | 0.090 |
Why?
|
| Military Personnel | 1 | 1993 | 221 | 0.090 |
Why?
|
| Schools | 1 | 2012 | 156 | 0.090 |
Why?
|
| Staphylococcus | 1 | 1991 | 29 | 0.090 |
Why?
|
| Graft Rejection | 1 | 2014 | 458 | 0.090 |
Why?
|
| Environmental Exposure | 1 | 2013 | 269 | 0.090 |
Why?
|
| Metabolic Syndrome | 1 | 2012 | 191 | 0.090 |
Why?
|
| Sexual Behavior | 4 | 2003 | 183 | 0.090 |
Why?
|
| Case-Control Studies | 5 | 2007 | 1553 | 0.090 |
Why?
|
| Myocardial Contraction | 1 | 2012 | 383 | 0.090 |
Why?
|
| Medication Systems, Hospital | 1 | 2010 | 19 | 0.090 |
Why?
|
| Polycyclic Compounds | 1 | 2010 | 5 | 0.090 |
Why?
|
| Heart Defects, Congenital | 2 | 2012 | 596 | 0.090 |
Why?
|
| Colonic Neoplasms | 1 | 2012 | 299 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2012 | 222 | 0.090 |
Why?
|
| Kidney Calculi | 1 | 2010 | 19 | 0.090 |
Why?
|
| West Virginia | 2 | 2020 | 11 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 446 | 0.090 |
Why?
|
| Sinusitis | 1 | 2015 | 432 | 0.090 |
Why?
|
| Prevalence | 6 | 2014 | 1619 | 0.090 |
Why?
|
| Foster Home Care | 1 | 1989 | 5 | 0.090 |
Why?
|
| Disease Susceptibility | 2 | 2007 | 179 | 0.090 |
Why?
|
| Trophoblasts | 3 | 2009 | 29 | 0.090 |
Why?
|
| Pesticides | 1 | 2010 | 41 | 0.090 |
Why?
|
| Family Characteristics | 1 | 1989 | 44 | 0.080 |
Why?
|
| Physicians | 1 | 2013 | 324 | 0.080 |
Why?
|
| Parent-Child Relations | 1 | 1989 | 98 | 0.080 |
Why?
|
| Absorptiometry, Photon | 1 | 2009 | 83 | 0.080 |
Why?
|
| Fetal Membranes, Premature Rupture | 2 | 2008 | 45 | 0.080 |
Why?
|
| Temporal Arteries | 1 | 2008 | 7 | 0.080 |
Why?
|
| Thermography | 1 | 2008 | 20 | 0.080 |
Why?
|
| Hawaii | 3 | 2007 | 24 | 0.080 |
Why?
|
| Disabled Children | 1 | 2008 | 16 | 0.080 |
Why?
|
| Neonatal Screening | 1 | 2008 | 43 | 0.080 |
Why?
|
| Chronic Disease | 2 | 2015 | 1330 | 0.080 |
Why?
|
| Body Temperature | 1 | 2008 | 116 | 0.080 |
Why?
|
| Skin | 2 | 2007 | 451 | 0.080 |
Why?
|
| Levonorgestrel | 1 | 2007 | 6 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2013 | 767 | 0.070 |
Why?
|
| Polybrominated Biphenyls | 1 | 2007 | 2 | 0.070 |
Why?
|
| Marriage | 2 | 2002 | 30 | 0.070 |
Why?
|
| Fetal Macrosomia | 1 | 2007 | 7 | 0.070 |
Why?
|
| Mental Disorders | 1 | 1993 | 659 | 0.070 |
Why?
|
| Developmental Disabilities | 1 | 2008 | 119 | 0.070 |
Why?
|
| Sensitivity and Specificity | 4 | 2015 | 1753 | 0.070 |
Why?
|
| Cefazolin | 1 | 2007 | 19 | 0.070 |
Why?
|
| Population Dynamics | 1 | 2007 | 30 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 70 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2008 | 504 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 2324 | 0.070 |
Why?
|
| Smoking | 1 | 2014 | 1452 | 0.070 |
Why?
|
| Bacteriuria | 1 | 2006 | 7 | 0.070 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2006 | 15 | 0.070 |
Why?
|
| Diabetes, Gestational | 1 | 2007 | 81 | 0.070 |
Why?
|
| Expert Systems | 1 | 2006 | 9 | 0.070 |
Why?
|
| Postpartum Period | 2 | 2020 | 67 | 0.070 |
Why?
|
| Sickle Cell Trait | 1 | 2006 | 24 | 0.070 |
Why?
|
| Rectum | 2 | 2008 | 62 | 0.070 |
Why?
|
| Risk Management | 1 | 2006 | 37 | 0.070 |
Why?
|
| Smoking Cessation | 1 | 2014 | 1034 | 0.070 |
Why?
|
| Echinacea | 1 | 2005 | 1 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 2 | 2000 | 329 | 0.070 |
Why?
|
| Rhinovirus | 1 | 2005 | 15 | 0.060 |
Why?
|
| Common Cold | 1 | 2005 | 8 | 0.060 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2006 | 37 | 0.060 |
Why?
|
| Animals | 9 | 2013 | 20881 | 0.060 |
Why?
|
| Bacterial Infections | 1 | 2007 | 163 | 0.060 |
Why?
|
| Cesarean Section, Repeat | 1 | 2005 | 4 | 0.060 |
Why?
|
| Patient Transfer | 2 | 1998 | 86 | 0.060 |
Why?
|
| Hemoptysis | 1 | 2005 | 28 | 0.060 |
Why?
|
| Pneumothorax | 1 | 2005 | 42 | 0.060 |
Why?
|
| Phytotherapy | 1 | 2005 | 53 | 0.060 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2006 | 92 | 0.060 |
Why?
|
| Allergens | 2 | 2015 | 54 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 438 | 0.060 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2006 | 88 | 0.060 |
Why?
|
| France | 2 | 2019 | 26 | 0.060 |
Why?
|
| Safety | 2 | 2005 | 145 | 0.060 |
Why?
|
| Plant Extracts | 1 | 2005 | 122 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2010 | 711 | 0.060 |
Why?
|
| Epilepsy | 1 | 2008 | 336 | 0.060 |
Why?
|
| Age Distribution | 1 | 2004 | 320 | 0.060 |
Why?
|
| Interinstitutional Relations | 1 | 2003 | 49 | 0.060 |
Why?
|
| Intubation, Intratracheal | 1 | 2004 | 99 | 0.060 |
Why?
|
| Health Services Accessibility | 2 | 2002 | 581 | 0.060 |
Why?
|
| Public Health Informatics | 1 | 2003 | 7 | 0.060 |
Why?
|
| Self Administration | 2 | 2015 | 419 | 0.060 |
Why?
|
| Developing Countries | 1 | 2004 | 106 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2004 | 1465 | 0.060 |
Why?
|
| Bias | 3 | 2000 | 148 | 0.050 |
Why?
|
| Twins | 2 | 1993 | 42 | 0.050 |
Why?
|
| Lead Poisoning | 1 | 2003 | 23 | 0.050 |
Why?
|
| Geographic Information Systems | 1 | 2003 | 34 | 0.050 |
Why?
|
| Housing | 1 | 2003 | 38 | 0.050 |
Why?
|
| Insurance, Health | 1 | 2004 | 201 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2008 | 657 | 0.050 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2003 | 18 | 0.050 |
Why?
|
| Primary Prevention | 1 | 2003 | 115 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2000 | 848 | 0.050 |
Why?
|
| Child Welfare | 1 | 2003 | 53 | 0.050 |
Why?
|
| Cross-Sectional Studies | 4 | 2012 | 2279 | 0.050 |
Why?
|
| California | 1 | 2002 | 99 | 0.050 |
Why?
|
| Congenital Abnormalities | 2 | 2004 | 42 | 0.050 |
Why?
|
| Postoperative Period | 2 | 2014 | 238 | 0.050 |
Why?
|
| Caprylates | 2 | 2013 | 32 | 0.050 |
Why?
|
| Patient Discharge | 2 | 2015 | 294 | 0.050 |
Why?
|
| Incest | 1 | 2002 | 6 | 0.050 |
Why?
|
| ROC Curve | 2 | 2018 | 392 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2005 | 378 | 0.050 |
Why?
|
| Total Quality Management | 1 | 2002 | 45 | 0.050 |
Why?
|
| Employment | 2 | 2012 | 154 | 0.050 |
Why?
|
| Registries | 2 | 2015 | 733 | 0.050 |
Why?
|
| Trial of Labor | 1 | 2001 | 5 | 0.050 |
Why?
|
| Uterine Rupture | 1 | 2001 | 4 | 0.050 |
Why?
|
| Candida | 1 | 2001 | 15 | 0.050 |
Why?
|
| Fluconazole | 1 | 2001 | 26 | 0.050 |
Why?
|
| Clinical Protocols | 1 | 2001 | 172 | 0.050 |
Why?
|
| Drug Administration Schedule | 2 | 2015 | 567 | 0.050 |
Why?
|
| Feeding Methods | 1 | 2020 | 17 | 0.050 |
Why?
|
| Spermatozoa | 2 | 1998 | 75 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2015 | 216 | 0.050 |
Why?
|
| Survival Rate | 2 | 2014 | 1056 | 0.050 |
Why?
|
| Rural Population | 1 | 2003 | 398 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2001 | 108 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 1026 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2002 | 453 | 0.040 |
Why?
|
| Madagascar | 1 | 2019 | 1 | 0.040 |
Why?
|
| Anemia | 1 | 2001 | 104 | 0.040 |
Why?
|
| Down Syndrome | 1 | 2001 | 120 | 0.040 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2001 | 123 | 0.040 |
Why?
|
| Blood Pressure | 2 | 2003 | 1451 | 0.040 |
Why?
|
| Cultural Characteristics | 1 | 1999 | 42 | 0.040 |
Why?
|
| Length of Stay | 2 | 2012 | 780 | 0.040 |
Why?
|
| Personality Inventory | 1 | 2000 | 197 | 0.040 |
Why?
|
| Algorithms | 2 | 2002 | 1196 | 0.040 |
Why?
|
| Hospitals, District | 1 | 1998 | 2 | 0.040 |
Why?
|
| Vaccination | 1 | 2020 | 189 | 0.040 |
Why?
|
| Public Health Practice | 1 | 2018 | 23 | 0.040 |
Why?
|
| Social Class | 1 | 1999 | 127 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2000 | 392 | 0.040 |
Why?
|
| Oocyte Donation | 1 | 1998 | 1 | 0.040 |
Why?
|
| Insemination, Artificial, Heterologous | 1 | 1998 | 3 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2000 | 714 | 0.040 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 1995 | 32 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 3259 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 1999 | 1054 | 0.040 |
Why?
|
| Maternal-Child Health Centers | 1 | 1997 | 3 | 0.040 |
Why?
|
| Fetal Diseases | 1 | 1998 | 64 | 0.040 |
Why?
|
| Health Maintenance Organizations | 1 | 1997 | 22 | 0.040 |
Why?
|
| Sepsis | 2 | 2007 | 233 | 0.040 |
Why?
|
| Birth Certificates | 2 | 1995 | 16 | 0.040 |
Why?
|
| Sexual Partners | 1 | 1998 | 106 | 0.040 |
Why?
|
| Aged | 2 | 2012 | 14862 | 0.040 |
Why?
|
| Sex Factors | 3 | 2010 | 1266 | 0.040 |
Why?
|
| Body Weight | 2 | 2006 | 554 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2017 | 304 | 0.030 |
Why?
|
| Data Collection | 2 | 2008 | 420 | 0.030 |
Why?
|
| Menstrual Cycle | 2 | 1995 | 64 | 0.030 |
Why?
|
| Pollen | 1 | 2015 | 6 | 0.030 |
Why?
|
| Hospitalization | 1 | 2001 | 978 | 0.030 |
Why?
|
| Dosage Forms | 1 | 2015 | 20 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2015 | 87 | 0.030 |
Why?
|
| Drug Labeling | 1 | 2015 | 32 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2015 | 62 | 0.030 |
Why?
|
| Neonatology | 1 | 1995 | 29 | 0.030 |
Why?
|
| Ligation | 1 | 2015 | 83 | 0.030 |
Why?
|
| Birth Rate | 1 | 1995 | 6 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2012 | 1745 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 2 | 1994 | 74 | 0.030 |
Why?
|
| Sex Characteristics | 2 | 2007 | 295 | 0.030 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2014 | 13 | 0.030 |
Why?
|
| Coitus | 1 | 1994 | 12 | 0.030 |
Why?
|
| Anaerobic Threshold | 1 | 2014 | 13 | 0.030 |
Why?
|
| Gastric Acid | 1 | 1995 | 71 | 0.030 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2014 | 57 | 0.030 |
Why?
|
| Meconium | 1 | 1994 | 2 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2015 | 141 | 0.030 |
Why?
|
| Epinephrine | 1 | 2014 | 103 | 0.030 |
Why?
|
| Outpatients | 1 | 2015 | 127 | 0.030 |
Why?
|
| Amniotic Fluid | 1 | 1994 | 30 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 2 | 1992 | 219 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2008 | 58 | 0.030 |
Why?
|
| Philippines | 1 | 1993 | 5 | 0.030 |
Why?
|
| Hypoxia | 1 | 1995 | 169 | 0.030 |
Why?
|
| Death Certificates | 1 | 1993 | 9 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2016 | 419 | 0.030 |
Why?
|
| Medical Record Linkage | 1 | 1993 | 42 | 0.030 |
Why?
|
| Rorschach Test | 1 | 1993 | 2 | 0.030 |
Why?
|
| Streptococcus agalactiae | 1 | 1993 | 26 | 0.030 |
Why?
|
| Tennessee | 1 | 1993 | 11 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 258 | 0.030 |
Why?
|
| Escherichia coli Infections | 1 | 1993 | 47 | 0.030 |
Why?
|
| Pregnancy, Multiple | 1 | 1993 | 32 | 0.030 |
Why?
|
| Urban Population | 2 | 2007 | 255 | 0.030 |
Why?
|
| Cervix Uteri | 1 | 1993 | 64 | 0.030 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 1993 | 11 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2006 | 306 | 0.030 |
Why?
|
| Decanoic Acids | 1 | 2013 | 5 | 0.030 |
Why?
|
| Demography | 2 | 1991 | 279 | 0.030 |
Why?
|
| Cause of Death | 1 | 1994 | 241 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 1993 | 53 | 0.030 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2013 | 37 | 0.030 |
Why?
|
| Reference Values | 2 | 2008 | 579 | 0.030 |
Why?
|
| Fontan Procedure | 1 | 2014 | 129 | 0.030 |
Why?
|
| Indian Ocean Islands | 1 | 2012 | 1 | 0.030 |
Why?
|
| Linear Models | 1 | 2014 | 521 | 0.030 |
Why?
|
| Obstetric Labor, Premature | 1 | 1993 | 76 | 0.030 |
Why?
|
| Physical Examination | 1 | 1993 | 152 | 0.030 |
Why?
|
| Alkanesulfonic Acids | 1 | 2013 | 54 | 0.030 |
Why?
|
| SEER Program | 1 | 2012 | 153 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2012 | 59 | 0.030 |
Why?
|
| Osteocalcin | 1 | 1992 | 37 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 1992 | 71 | 0.030 |
Why?
|
| Water Pollution, Chemical | 1 | 2011 | 12 | 0.030 |
Why?
|
| Staphylococcal Infections | 1 | 1993 | 156 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2012 | 122 | 0.020 |
Why?
|
| Hospitals, University | 3 | 2001 | 169 | 0.020 |
Why?
|
| Benzhydryl Compounds | 1 | 2012 | 62 | 0.020 |
Why?
|
| Phenols | 1 | 2012 | 73 | 0.020 |
Why?
|
| Decision Making | 2 | 2006 | 410 | 0.020 |
Why?
|
| Surveys and Questionnaires | 2 | 2013 | 2800 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 139 | 0.020 |
Why?
|
| Calcifediol | 1 | 1991 | 70 | 0.020 |
Why?
|
| Internet | 2 | 2006 | 390 | 0.020 |
Why?
|
| Methylprednisolone | 1 | 2012 | 99 | 0.020 |
Why?
|
| Causality | 1 | 1991 | 82 | 0.020 |
Why?
|
| Anniversaries and Special Events | 1 | 2011 | 12 | 0.020 |
Why?
|
| Apgar Score | 2 | 2005 | 22 | 0.020 |
Why?
|
| Infant, Premature, Diseases | 1 | 1992 | 85 | 0.020 |
Why?
|
| Nutritional Requirements | 1 | 1991 | 57 | 0.020 |
Why?
|
| Florida | 1 | 2011 | 221 | 0.020 |
Why?
|
| Chi-Square Distribution | 2 | 2006 | 546 | 0.020 |
Why?
|
| Specimen Handling | 1 | 1991 | 47 | 0.020 |
Why?
|
| Education | 1 | 2011 | 83 | 0.020 |
Why?
|
| Nephrolithiasis | 1 | 2010 | 9 | 0.020 |
Why?
|
| Educational Status | 1 | 1991 | 273 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2010 | 79 | 0.020 |
Why?
|
| Environmental Pollutants | 1 | 2012 | 180 | 0.020 |
Why?
|
| Baltimore | 1 | 1989 | 34 | 0.020 |
Why?
|
| West Indies | 3 | 1994 | 5 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2012 | 403 | 0.020 |
Why?
|
| Lung | 1 | 1994 | 849 | 0.020 |
Why?
|
| Southeastern United States | 1 | 2010 | 281 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2009 | 94 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2009 | 114 | 0.020 |
Why?
|
| Fever | 1 | 2008 | 96 | 0.020 |
Why?
|
| Blood Gas Analysis | 1 | 2008 | 41 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2008 | 57 | 0.020 |
Why?
|
| Elective Surgical Procedures | 1 | 2008 | 95 | 0.020 |
Why?
|
| Atlantic Ocean | 1 | 2007 | 22 | 0.020 |
Why?
|
| Geography | 1 | 2007 | 80 | 0.020 |
Why?
|
| Child Abuse | 1 | 1989 | 186 | 0.020 |
Why?
|
| Body Burden | 1 | 2007 | 27 | 0.020 |
Why?
|
| Umbilical Cord | 1 | 2007 | 19 | 0.020 |
Why?
|
| Constriction | 1 | 2007 | 37 | 0.020 |
Why?
|
| Endometritis | 1 | 2007 | 29 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2007 | 62 | 0.020 |
Why?
|
| Body Height | 1 | 2006 | 67 | 0.020 |
Why?
|
| Cystitis | 1 | 2006 | 18 | 0.020 |
Why?
|
| Pyelonephritis | 1 | 2006 | 17 | 0.020 |
Why?
|
| Calcium | 2 | 2006 | 929 | 0.020 |
Why?
|
| Income | 1 | 2007 | 167 | 0.020 |
Why?
|
| Programming Languages | 1 | 2006 | 16 | 0.020 |
Why?
|
| Mass Screening | 1 | 2012 | 843 | 0.020 |
Why?
|
| Skin Pigmentation | 1 | 2006 | 25 | 0.020 |
Why?
|
| Poverty | 1 | 2007 | 219 | 0.020 |
Why?
|
| Sunlight | 1 | 2006 | 59 | 0.020 |
Why?
|
| Nasal Lavage Fluid | 1 | 2005 | 4 | 0.020 |
Why?
|
| Patient Care Team | 2 | 2001 | 311 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2007 | 168 | 0.020 |
Why?
|
| Lipids | 1 | 2007 | 298 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2005 | 71 | 0.020 |
Why?
|
| Respiration Disorders | 1 | 2005 | 20 | 0.020 |
Why?
|
| Creatinine | 1 | 2006 | 243 | 0.020 |
Why?
|
| Fetal Organ Maturity | 1 | 2004 | 3 | 0.020 |
Why?
|
| Hematuria | 1 | 2005 | 24 | 0.020 |
Why?
|
| Blood Coagulation Disorders | 1 | 2005 | 45 | 0.020 |
Why?
|
| Acidosis | 1 | 2005 | 31 | 0.020 |
Why?
|
| Bradycardia | 1 | 2005 | 45 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 1987 | 264 | 0.020 |
Why?
|
| Acute Disease | 1 | 2006 | 658 | 0.010 |
Why?
|
| Neutrophils | 1 | 2005 | 204 | 0.010 |
Why?
|
| Child Development | 1 | 2005 | 102 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2005 | 122 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 4848 | 0.010 |
Why?
|
| Postal Service | 1 | 2003 | 19 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 1040 | 0.010 |
Why?
|
| Lead | 1 | 2003 | 45 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2005 | 298 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2005 | 402 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2003 | 219 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1851 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2003 | 189 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 2005 | 232 | 0.010 |
Why?
|
| Software Design | 1 | 2001 | 18 | 0.010 |
Why?
|
| Motor Activity | 1 | 2005 | 621 | 0.010 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2001 | 15 | 0.010 |
Why?
|
| Candidiasis | 1 | 2001 | 39 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 2001 | 70 | 0.010 |
Why?
|
| Cognition | 1 | 2005 | 513 | 0.010 |
Why?
|
| Software | 1 | 2003 | 418 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2001 | 226 | 0.010 |
Why?
|
| Risk | 2 | 1993 | 563 | 0.010 |
Why?
|
| Spinal Dysraphism | 1 | 1998 | 8 | 0.010 |
Why?
|
| Hernia, Umbilical | 1 | 1998 | 10 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1998 | 63 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1998 | 95 | 0.010 |
Why?
|
| Ancillary Services, Hospital | 1 | 1997 | 1 | 0.010 |
Why?
|
| Patient Participation | 1 | 1997 | 146 | 0.010 |
Why?
|
| Infant Food | 1 | 1995 | 16 | 0.010 |
Why?
|
| Program Evaluation | 1 | 1997 | 502 | 0.010 |
Why?
|
| Gastric Acidity Determination | 1 | 1995 | 62 | 0.010 |
Why?
|
| Health Care Costs | 1 | 1998 | 346 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 1995 | 77 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 1995 | 117 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1995 | 618 | 0.010 |
Why?
|
| Nurse Midwives | 1 | 1993 | 21 | 0.010 |
Why?
|
| Medical Indigency | 1 | 1992 | 7 | 0.010 |
Why?
|
| Infant, Postmature | 1 | 1992 | 2 | 0.010 |
Why?
|
| Infant, Small for Gestational Age | 1 | 1992 | 46 | 0.010 |
Why?
|
| Phosphorus | 1 | 1991 | 64 | 0.010 |
Why?
|
| Calcitriol | 1 | 1992 | 106 | 0.010 |
Why?
|
| Bone and Bones | 1 | 1992 | 145 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 1991 | 117 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1991 | 411 | 0.010 |
Why?
|
| Menstruation | 1 | 1990 | 20 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1990 | 219 | 0.010 |
Why?
|
| Research Design | 1 | 1992 | 729 | 0.000 |
Why?
|
| Abortion, Induced | 1 | 1987 | 18 | 0.000 |
Why?
|